Skip to main content
OpenTrials
Completed

NCT Number: NCT03787810

Left Ventricular Dysfunction in Critically Ill Patients

Left ventricular dysfunction is common in the critically ill. The aim of this study is to assess the incidence and prognosis of left ventricular dysfunction in critically ill patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Left Ventricular Dysfunction Acute Coronary Syndrome Cardiomyopathies Cardiovascular Diseases Critical Illness Critically Ill Disease Attributes Heart Diseases Myocardial Ischemia Pathologic Processes Pathological Conditions, Signs and Symptoms Takotsubo Cardiomyopathy Vascular Diseases Ventricular Dysfunction Ventricular Dysfunction, Left

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Sahlgrenska University Hospital

Gothenburg, Västra Götalandsregionen, 41345, Sweden

About this study

Left ventricular dysfunction is common in the critically ill. A number of conditions can cause left ventricular dysfunction including myocardial infarction, septic cardiomyopathy, post resuscitation syndrome, takotsubo syndrome etc. A number of studies have assessed cardiac dysfunction in specific conditions (e.g. sepsis, cardiac arrest) but only a few studies have assessed cardiac dysfunction in a general ICU-population. The study will focus on diagnostics of the different types of cardiomyopathy and differentiating between ischemic and non-ischemic left ventricular dysfunction in a general ICU population. The aim of this study is to assess the incidence and prognosis of the different types of left ventricular dysfunction in critically ill patients. Our hypothesis is that left ventricular dysfunction is common in the critically ill and is associated with an increased risk of short-term death.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Admitted within 24 hours to the ICU
  • Dysfunction of at least one organ system, defined as at least +1 point in SOFA-score.

Exclusion criteria

-

Treatment and study plan

Echocardiography

Diagnostic Test

Echocardiography for assessment of left ventricular dysfunction

Primary outcomes

  1. Mortality

    Time frame: 30 days

    All cause mortality after admission to the ICU

Sponsors and collaborators

Lead sponsor

Sahlgrenska University Hospital

Other

Registry information

Acronym: LEVEDYCIP

Important dates

Study start
2018
Primary completion
2019
Study completion
2020
First posted
Dec 26, 2018
Registry last updated
Apr 24, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.